Skip to content

Clinical trials

Observational Obesity trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Observational Country / region: United Arab Emirates Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20151
20162
20182
20191
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
Imperial College London Diabetes Centre2
Corniche Hospital1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
University of Sharjah1
University of Warwick1
Zayed University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity10
Diabetes Mellitus2
Overweight2
Diabetes Mellitus, Type 21
Diabetes, Gestational1
Dysbiosis1
Dyslipidemias1
Glucose Intolerance1
Hypertension1
Insulin Resistance1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.